The accuracy of the RapID-ANA II system (Innovative Diagnostic Systems, Inc., Atlanta, Ga.) was evaluated by comparing the results obtained with that system with results obtained by the methods described by the Virginia Polytechnic Institute and State University. Three hundred anaerobic bacteria were tested, including 259 clinical isolates and 41 stock strains of anaerobic microorganisms representing 16 genera and 48 species. When identifications to the genus level only were included, 96% of the anaerobic gram-negative bacilli, 94% of the Clostridium species, 83% of the anaerobic, nonsporeforming, gram-positive bacilli, and 97% of the anaerobic cocci were correctly identified. When correct identifications to the genus and species levels were compared, 86% of 152 anaerobic gram-negative bacilli, 76% of 34 Clostridium species, 81% of 41 anaerobic, nonsporeforming, gram-positive bacilli, and 97% of 73 anaerobic cocci were correctly identified. Eight isolates (3%) produced inadequate identifications in which the correct identification was listed with one or two other possible choices and extra tests were required for separation. A total of 9 isolates (3%) were misidentified by the RapID-ANA II panel. Overall, the system was able to correctly identify 94% of all the isolates to the genus level and 87% of the isolates to the species level in 4 h by using aerobic incubation.
Time-consuming biochemical testing under strict anaerobic conditions and gas-liquid chromatographic analysis of short-chain fatty acid metabolites of glucose fermentation have traditionally marked the methods for the identification of anaerobic bacteria (13, 19) . These conventional methods are labor intensive, time consuming, expensive, and beyond the means of most clinical microbiology laboratories. Many of the original commercial kit systems were dependent upon the growth of the anaerobic organisms and therefore required 24 to 48 h or more of anaerobic incubation before test results were generated (2) .
In recent years, kit systems have been developed for the identification of clinically relevant anaerobic bacteria that are not growth dependent and that do not require anaerobic incubation. These systems are based on the detection of preformed bacterial enzymes (23) and include the RapID-ANA (Innovative Diagnostic Systems, Inc., Atlanta, Ga.) (1, 3, 4, 6, 8-12, 15, 17, 20, 21, 28) , the AN-Ident system (Analytab Products) (4, 6, 12, 21, 27, 29) , the Anaerobe Identification card (Vitek Systems, Hazelwood, Mo.) (24) , the 2-h ABL system (Austin Biological Systems, Austin, Tex. [22] ), the ATB 32A system (API System SA, La Balme les Grottes, Montalieu-Vercieu, France) (18) , and the MicroScan system (American MicroScan, Sacramento, Calif.).
Innovative Diagnostic Systems, Inc., has revised the original RapID-ANA panel through the deletion of triphenyl tetrazolium reduction, rapid arginine dihydrolase, and trehalose. Three new substrates, namely, urea, p-nitrophenyl-,3-D-disaccharide (BLTS) , and p-nitrophenyl-a-L-arabi- The purpose of this study was to evaluate the accuracy of the RapID-ANA II for the identification of clinically significant anaerobic bacteria. Results obtained with the RapID-ANA II panel were compared with those obtained by the methods described by the Virginia Polytechnic Institute and State University, Blacksburg (13) .
(Part of this work was presented at the 90th Annual Meeting of the American Society for Microbiology [7] .) ylococcus saccharolyticus, and nine Veillonella spp. were also correctly identified.
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In this study, the RapID-ANA II system was evaluated for its ability to identify a wide variety of anaerobic bacteria recovered in the clinical laboratory. After familiarization with the various types of color reactions produced by organisms in the various substrates, the interpretation of most of the tests on the panel was not difficult. The yellow colors resulting from the o-or p-nitrophenol reactions and the dark pink to purple color from the ,3-naphthylamine reactions were generally clear-cut. Both the urea and indole reactions were easily interpreted.
In reviewing the initial studies performed on the original RapID-ANA panel, the Anldent panel and the Vitek ANI card, widely varying percentages of accuracy have been reported. In previous studies performed on the first RapID-ANA system, 59 to 92% of anaerobic gram-negative bacilli, 66 to 100% of clostridia, 50 to 100% of nonsporeforming gram-positive bacilli, and 78 to 100% of anaerobic cocci were correctly identified by the system compared with correct identifications by various conventional methods (1, 3, 4, 6, 8-12, 15, 17, 20, 21, 28) . The wide variations in performance of these systems are related to the numbers, types, and sources (e.g., stock strains, human clinical isolates, and veterinary strains) of organisms tested, whether the additional tests suggested by the systems' computer-generated There was no single test in the RapID-ANA II system that separated these two species. Consequently, 7 of 10 Bacteroides ovatus isolates were identified to the group level only as the Bacteroides fragilis group, with Bacteroides ovatus and Bacteroides uniformis being possible identifications of the organism. Two additional strains of Bacteroides ovatus were incorrectly identified as Bacteroides thetaiotaomicron because of positive arginine reactions in the RapID-ANA II panel. The system used arginine and serine as key tests in separating Bacteroides thetaiotaomicron (usually positive) from Bacteroides ovatus and Bacteroides uniformis (usually negative). The RapID-ANA II data base shows that only 11% of Bacteroides ovatus isolates should be positive for arginine.
Two strains of Bacteroides uniformis were also identified to the group level only as the Bacteroidesfragilis group, with Bacteroides ovatus and Bacteroides uniformis being the suggested identifications. This was due to a positive reaction with aARA. Bacteroides uniformis is listed as 81% positive for aARA and Bacteroides ovatus is listed as 95% positive for aARA in the RapID-ANA II data base. When this test is negative, the isolate keys out as Bacteroides uniformis. However, when the test is positive, as occurred with two of our isolates, the organism keys out as a Bacteroides fragilis group isolate. One additional strain keyed out as an inadequate identification, with Bacteroides eggerthii and Bacteroides ovatus being the possible choices. The problem here was traced to a negative L-fucoside reaction (Bacteroides uniformis is 95% positive) and a positive glycine reaction (Bacteroides uniformis is 12% positive).
Since the indole-positive strains of the Bacteroidesfragilis group are routinely more resistant to a greater number of antibiotics, it is suggested that when reporting the grouplevel identification, the report should be amended to state that the organism is one of the indole-positive strains.
Various problems were listed in previously published reports that reviewed the first RapID-ANA system. A major problem cited in several reports addressed the interpretation of the aryl and amide color reactions, variability in test result interpretations by different personnel, and the initial color in the wells becoming obscured by the addition of the secondary reagents (6, 9, 17) . The last concern still applies to the RapID-ANA II system; however, interpretation of the color reactions was not considered to be a problem in this study. Referral to the color reaction card available from the manufacturer helped in resolving color interpretations. In this study, all tests were read by one person, eliminating variability in test result interpretations by different personnel. In the study by Karachewski et al. (17) , 23% of code numbers generated were not listed in the Code Compendium. In this study, all code numbers were listed in the updated version of the Code Compendium (16) .
The RapID-ANA II system performed well in identifying certain Clostridium spp., particularly Clostridium perfringens (100%), and Propionibacterium spp. (91%), but it performed less well with other species of gram-positive bacilli and needs to be tested with larger numbers of organisms in order to fully evaluate the system's performance with this group of organisms. The addition of the updated data base, updated nomenclature, new code sheets, and the substitution of three tests has enhanced the system and leads to improved overall performance.
In summary, we found the RapID-ANA II panel to be an acceptable rapid test system for identifying most of the clinically significant anaerobic bacteria tested in this study. The decrease in the amount of labor involved in the identification of anaerobic organisms and the more rapid definitive identification help to provide a more timely diagnostic service in clinical anaerobic bacteriology laboratories.
